Asia Medical and Agricultural Laboratory and Research Center PCL (AMARC) Stock Statistics & Valuation Metrics
Total Valuation
Asia Medical and Agricultural Laboratory and Research Center PCL has a market cap or net worth of THB 1.15B. The enterprise value is THB 1.26B.
- Market Cap
- THB 1.15B
- Enterprise Value
- THB 1.26B
Share Statistics
Asia Medical and Agricultural Laboratory and Research Center PCL has 420,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 420,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Asia Medical and Agricultural Laboratory and Research Center PCL’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 22.96%.
- Return on Equity (ROE)
- 0.26
- Return on Assets (ROA)
- 0.22
- Return on Invested Capital (ROIC)
- 22.96%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 2.22M
- Profits Per Employee
- 717.47K
- Employee Count
- 221
- Asset Turnover
- 0.69
- Inventory Turnover
- 17.64
Valuation Ratios
The current PE Ratio of Asia Medical and Agricultural Laboratory and Research Center PCL is 9.09. Asia Medical and Agricultural Laboratory and Research Center PCL’s PEG ratio is 0.09.
- PE Ratio
- 9.09
- PS Ratio
- 2.41
- PB Ratio
- 1.94
- Price to FCF
- 11.23
- Price to Operating Cash Flow
- 7.82
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, Asia Medical and Agricultural Laboratory and Research Center PCL had revenue of 491.01M and earned 158.56M in profits. Earnings per share was 0.38.
- Revenue
- 491.01M
- Gross Profit
- 265.29M
- Operating Income
- 154.62M
- Pretax Income
- 157.31M
- Net Income
- 158.56M
- EBITDA
- 196.13M
- Earnings Per Share (EPS)
- 0.38
Cash Flow
In the last 12 months, operating cash flow was 145.11M and capital expenditures -45.97M, giving a free cash flow of 99.15M billion.
- Operating Cash Flow
- 145.11M
- Free Cash Flow
- 99.15M
- Free Cash Flow per Share
- 0.24
Dividends & Yields
Asia Medical and Agricultural Laboratory and Research Center PCL pays an annual dividend of ―, resulting in a dividend yield of 9.12%
- Dividend Per Share
- ―
- Dividend Yield
- 9.12%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.91%
- Earnings Yield
- 11.20%
Stock Price Statistics
- Beta
- 1.19
- 52-Week Price Change
- -7.43%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 33.06
- Average Volume (3m)
- 1.12M
Important Dates
Asia Medical and Agricultural Laboratory and Research Center PCL upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
Asia Medical and Agricultural Laboratory and Research Center PCL as a current ratio of 4.78, with Debt / Equity ratio of 3.49%
- Current Ratio
- 4.78
- Quick Ratio
- 4.55
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.13
- Interest Coverage Ratio
- 161.52
Taxes
In the past 12 months, Asia Medical and Agricultural Laboratory and Research Center PCL has paid -1.25M in taxes.
- Income Tax
- -1.25M
- Effective Tax Rate
- -0.01
Enterprise Valuation
Asia Medical and Agricultural Laboratory and Research Center PCL EV to EBITDA ratio is 5.99, with an EV/FCF ratio of 10.03.
- EV to Sales
- 2.15
- EV to EBITDA
- 5.99
- EV to Free Cash Flow
- 10.03
- EV to Operating Cash Flow
- 6.85
Balance Sheet
Asia Medical and Agricultural Laboratory and Research Center PCL has THB 144.18M in cash and marketable securities with THB 24.86M in debt, giving a net cash position of THB 119.32M billion.
- Cash & Marketable Securities
- THB 144.18M
- Total Debt
- THB 24.86M
- Net Cash
- THB 119.32M
- Net Cash Per Share
- THB 0.28
- Tangible Book Value Per Share
- THB 1.36
Margins
Gross margin is 50.27%, with operating margin of 26.78%, and net profit margin of 27.48%.
- Gross Margin
- 50.27%
- Operating Margin
- 26.78%
- Pretax Margin
- 27.01%
- Net Profit Margin
- 27.48%
- EBITDA Margin
- 35.88%
- EBIT Margin
- 26.78%
Analyst Forecast
The average price target for Asia Medical and Agricultural Laboratory and Research Center PCL is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 1.73%
- EPS Growth Forecast
- 1.03%

